Iovance Biotherapeutics competitorsClear all
Iovance Biotherapeutics's top competitors include Achilles Therapeutics, Ethypharm, Celltrion Healthcare and Pharmacyclics.
| Save Comparison |  Iovance Biotherapeutics Iovance Biotherapeutics (formerly Lion Biotechnologies) is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes. |  Achilles Therapeutics Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer. |  Ethypharm Ethypharm is a specialty pharmaceutical company focused on the treatment of pain and addiction. |  Celltrion Healthcare Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis., |  Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. |
Founding Date | Founding Date 2013 | Founding Date 2016 | Founding Date 1977 | Founding Date 2002 | Founding Date 1991 |
Type | Type Public | Type Private | Type Private | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations San Carlos, US HQ New York, US Philadelphia, US Philadelphia, US Tampa, US | Locations London, GB HQ Stevenage, GB | Locations KR HQ | Locations Sunnyvale, US HQ | |
Employees | Employees 14868% increase | Employees 153 | Employees 742 | Employees 6301% increase | Employees 7961% decrease |
Twitter followers | Twitter followers N/A | Twitter followers 361 | Twitter followers 222 | Twitter followers 591 | Twitter followers 1.2 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 4 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 6 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 2.8 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 30.8 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 50% |
Alexa Website Rank | Alexa Website Rank 597325 | Alexa Website Rank 296752 | Alexa Website Rank N/A | Alexa Website Rank 212471 | Alexa Website Rank 363463 |
Employee Rating | Employee Rating 2.9 | Employee Rating 3.9 | Employee Rating 3.3 | Employee Rating N/A | Employee Rating 3.7 |
Financial | |||||
Net income | Net income ($259.6m) (FY, 2020) | Net income ($33.2m) (FY, 2020) | Net income N/A | Net income N/A | Net income $86.1m (FY, 2014) |
Funding | |||||
Total funding raised | Total funding raised $ 100m | Total funding raised $ 138.1m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Achilles Therapeutics
HQ
London, GB
Employees
153
Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.
View companyEthypharm
HQ
Saint-Cloud, FR
Employees
742
Ethypharm is a specialty pharmaceutical company focused on the treatment of pain and addiction.
View companyCelltrion Healthcare
HQ
KR
Employees
630↑ 1% increase
Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis.,
View companyPharmacyclics
HQ
Sunnyvale, US
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
View company